Biblio

Export 2045 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2016
H. - L. Gao, Li, C., Nabeka, H., Shimokawa, T., Wang, Z. - Y., Cao, Y. - M., and Matsuda, S., “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
A. Boehm-Cagan, Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., and Michaelson, D. M., “ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
H. Li, Zhu, H., Wallack, M., Mwamburi, M., Abdul-Hay, S. O., Leissring, M. A., and Qiu, W. Qiao, “Age and its association with low insulin and high amyloid-β peptides in blood.”, J Alzheimers Dis, vol. 49, no. 1, pp. 129-37, 2016.
S. Matura, Prvulovic, D., Hartmann, D., Scheibe, M., Sepanski, B., Butz, M., Oertel-Knöchel, V., Knöchel, C., Karakaya, T., Fußer, F., Hattingen, E., and Pantel, J., “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
M. Heffernan, Mather, K. A., Xu, J., Assareh, A. A., Kochan, N. A., Reppermund, S., Draper, B., Trollor, J. N., Sachdev, P., and Brodaty, H., “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
A. Midorikawa, Leyton, C. E., Foxe, D., Landin-Romero, R., Hodges, J. R., and Piguet, O., “All Is Not Lost: Positive Behaviors in Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia with Disease Severity.”, J Alzheimers Dis, vol. 54, no. 2, pp. 549-58, 2016.
S. Yamashita, Kiko, T., Fujiwara, H., Hashimoto, M., Nakagawa, K., Kinoshita, M., Furukawa, K., Arai, H., and Miyazawa, T., “Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids.”, J Alzheimers Dis, vol. 50, no. 2, pp. 527-37, 2016.
M. Perkins, Wolf, A. B., Chavira, B., Shonebarger, D., Meckel, J. P., Leung, L., Ballina, L., Ly, S., Saini, A., T Jones, B., Vallejo, J., Jentarra, G., and Valla, J., “Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.”, J Alzheimers Dis, vol. 53, no. 1, pp. 95-106, 2016.
C. N. Clark, Nicholas, J. M., Gordon, E., Golden, H. L., Cohen, M. H., Woodward, F. J., Macpherson, K., Slattery, C. F., Mummery, C. J., Schott, J. M., Rohrer, J. D., and Warren, J. D., “Altered sense of humor in dementia.”, J Alzheimers Dis, vol. 49, no. 1, pp. 111-9, 2016.
C. N. Clark, Nicholas, J. M., Gordon, E., Golden, H. L., Cohen, M. H., Woodward, F. J., Macpherson, K., Slattery, C. F., Mummery, C. J., Schott, J. M., Rohrer, J. D., and Warren, J. D., “Altered sense of humor in dementia.”, J Alzheimers Dis, vol. 49, no. 1, pp. 111-9, 2016.
P. Maresova, Klimova, B., Novotny, M., and Kuca, K., “Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1123-1133, 2016.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
M. Abdullah, Takase, H., Nunome, M., Enomoto, H., Ito, J. - I., Gong, J. - S., and Michikawa, M., “Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
H. - C. Huang, Zheng, B. - W., Guo, Y., Zhao, J., Zhao, J. - Y., Ma, X. - W., and Jiang, Z. - F., “Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.”, J Alzheimers Dis, vol. 52, no. 3, pp. 899-911, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
E. Del Valle, Navarro, A., Martínez-Pinilla, E., Torices, S., and Tolivia, J., “Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?”, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
C. Yang, Huang, X., Huang, X., Mai, H., Li, J., Jiang, T., Wang, X., and Lü, T., “Aquaporin-4 and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 391-402, 2016.
E. Grossi, Stoccoro, A., Tannorella, P., Migliore, L., and Coppedè, F., “Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1517-22, 2016.
M. Mandecka, Budziszewska, M., Barczak, A., Pepłońska, B., Chodakowska-Żebrowska, M., Filipek-Gliszczyńska, A., Nesteruk, M., Styczyńska, M., Barcikowska, M., and Gabryelewicz, T., “Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 157-68, 2016.

Pages